Phleum pratense pollen allergy vaccine - HAL Allergy

Drug Profile

Phleum pratense pollen allergy vaccine - HAL Allergy

Alternative Names: Sublivac Fix Grasses; SUBLIVAC FIX Phleum pratense; Sublivac Fix Phleum pratense

Latest Information Update: 10 Nov 2016

Price : $50

At a glance

  • Originator HAL Allergy
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 01 Oct 2016 HAL Allergy completes a phase II trial in Allergic rhinitis in Canada (Sublingual) (NCT02556801)
  • 01 Sep 2015 Phase-II clinical trials in Allergic rhinitis in Canada (Sublingual)
  • 01 Sep 2015 Phase-II clinical trials in Allergic rhinoconjunctivitis in Canada (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top